Tumor junction burden and antigen presentation as predictors of survival in mesothelioma treated with immune checkpoint inhibitors.
暂无分享,去创建一个
Sarah H. Johnson | J. Cheville | A. Mansfield | M. Borad | F. Kosari | P. Baas | J. Smadbeck | G. Vasmatzis | T. Peikert | A. Desai | S. Murphy | J. Udell | G. Karagouga | M. Disselhorst | J. Schaefer-Klein | A. Mccune | J. Yin